US 7,575,547 B2
Cardiac support device with anti-fibrosis coating
Clifton A. Alferness, Redmond, Wash. (US); Jai Shankar Raman, North Baldwyn (Australia); and John Melmouth Power, Williamstown (Australia)
Assigned to Acorn Cardiovascular, Inc., St. Paul, Minn. (US)
Filed on Jun. 12, 2006, as Appl. No. 11/451,209.
Application 11/451209 is a division of application No. 10/810096, filed on Mar. 26, 2004, granted, now 7,153,258, filed on Dec. 26, 2006.
Application 10/810096 is a continuation of application No. 09/880576, filed on Jun. 13, 2001.
Application 09/880576 is a continuation of application No. 09/565621, filed on May 04, 2000, granted, now 6,537,203, filed on Mar. 25, 2003.
Application 09/565621 is a continuation of application No. 09/114510, filed on Jul. 13, 1998, granted, now 6,123,662, filed on Sep. 26, 2000.
Prior Publication US 2006/0235265 A1, Oct. 19, 2006
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/00 (2006.01)
U.S. Cl. 600—37 6 Claims
OG exemplary drawing
 
1. A method for treating a disease of a heart, the method comprising:
(a) selecting a device including:
a jacket constructed of a plurality of flexible elongated members interconnected to form a jacket material, wherein at least a portion of the individual elongated members are coated with an anti-fibrosis coating, and
wherein said jacket is adapted to be placed on said heart, said material is dimensioned so as to conform to an external geometry of said heart surrounding at least the ventricles to constrain circumferential expansion of said heart during diastole and permit substantially unimpeded contraction of said heart during systole;
(b) placing said jacket on said heart with said material surrounding at least the ventricles of said heart to constrain circumferential expansion of said heart during diastole and permit substantially unimpeded contraction of said heart during systole.